Value Microcaps Motherboard

[2morrowsGains]

CHME...Here's another market for China Medicine's ADTZ...
http://www.koreatimes.co.kr/www/news/nation/2008/04/117_22135.html
I have a feeling China Medicine is going to do very well with this product. Here are the comments made on ADTZ from CHME's latest cc...

- In 2007 we continued our R&D efforts and worked closely with our partners on our new drug pipeline. We’re particularly excited about the progress we’ve made in the development of aflatoxin detoxifizyme, or ADTZ, an enzyme that has shown efficacy in detecting and eliminating aflatoxin from food and animal feed.

Aflatoxin is a potential carcinogen causing liver, stomach and lung cancers in both animals and humans. It’s produced by the very common Aspergillus fungus and frequently affects cereal grains, oil seeds, spices and tree nuts. In addition to its efficacy in detoxifying food and animal feed, ADTZ has also shown initial promising results in treating liver and stomach cancer and has the potential for applications in transgenic technologies, such as transgenic peanuts with a resistance to aflatoxin.

We began work on ADTZ in July of 2006 when we established our joint venture company, Guangzhou Co-win Biotechnology, or Co-win, together with Ji’nan University and Mr. Dongsheng Yao, the scientist who originally developed the patents related to ADTZ.

In September of 2007 we received, as Mr. Yang mentioned, $800,000 RMB from the Education Department of Guangdong Province to support our ADTZ product development. And in October of 2007 our ADTZ project was selected as one of six patent commercialization projects in Guangdong Province.

As a result we will receive financial and other support from the provincial and local governments to assist in the rapid commercialization of this very innovative ADTZ.

We plan to apply for a production permit for the use of ADTZ in the treatment of animal feed and expect to begin trial sales in the latter half of 2008.

Thus you can see that we believe that ADTZ has applications in treating both animal feed and treating grain for human consumption and could eventually be deployed in overseas markets as well.

If we’re successful in obtaining the required permit in 2008 we believe we could begin to generate meaningful revenue from ADTZ beginning in 2009."

- "The status for ADTZ right now is they have already finished the development of the enzyme. In May they will be initiating the experiment with animals and in July they will be submitting their application for approval and the whole process takes about three to four months. So, in October the Company is expected to be ready for its trial sales of the product."

http://investorshub.advfn.com/boards/read_msg.asp?message_id=28104200